Abbott Laboratories

Abbott Laboratories Misses on EPS, Stock Down 1.06%

Abbott Laboratories reported an EPS of $0.98, which was below expectations, resulting in a stock decline of 1.06%. The lack of revenue data and guidance may contribute to investor uncertainty moving forward. The stock's reaction reflects the disappointment in earnings performance.